The future of injection molding in the medical sector: Innovation and trends
Injection molding in the medical sector has become one of the key technologies in the manufacturing of healthcare devices. Its ability to produce high-precision, biocompatible and scalable components positions it as a strategic pillar within the healthcare and medical industry.
Market Growth: Injection molding in the medical sector
The global medical injection molding market reached an approximate value of USD 24.8 billion in 2025 and is projected to exceed USD 42 billion by 2034, driven by a CAGR of 5.4%.
This growth is driven by several key factors:
- Increasing demand for high-precision medical devices
- Expansion of digital healthcare and wearable devices
- Growth in minimally invasive surgeries
- Need for injection molding parts manufacturing in cleanroom environments
Key drivers in the medical sector
Rise of minimally invasive surgery
The shift toward less invasive procedures is generating strong demand for components such as:
- Catheters
- Trocars
- Endoscopic components
These require sub-millimeter tolerances and complex geometries that only medical injection molding can deliver efficiently and with high repeatability.
Expansion of wearable medical devices
The growth of devices such as:
- Continuous glucose monitors
- Insulin pumps
- Biometric sensors
is driving the need for:
- Lightweight and durable materials
- Ergonomic design
- High biocompatibility for prolonged skin contact
Currently, the diagnostics and monitoring segment accounts for approximately 45% of the market.
Reshoring of injection molding production
Following global supply chain disruptions, the sector is shifting toward:
- Localized production (nearshoring / km 0)
- Reduced dependence on imports
- Greater quality control
This creates opportunities for specialized manufacturers with advanced production capabilities and regulatory compliance.
Future technological trends in medical injection molding
Liquid silicone rubber (LSR) and micro-molding
Liquid Silicone Rubber (LSR) is gaining relevance due to:
- High thermal and chemical resistance
- Excellent biocompatibility in biocompatible silicone
- Applications in sealing systems, valves, and implantable components
Micro-molding enables the production of components below 1 gram for critical applications such as:
- Ophthalmology
- Neurology
- Micro-implants
Digitalization and Industry 4.0
The adoption of smart technologies is transforming production:
- AI-driven sensors for real-time process control (as observed at our visit to BIEMH 2026)
- Full traceability (critical for FDA regulations and CE compliance)
- CAD/CAM simulation and digital twins
This enables:
- Reduction of defects
- Mold optimization
- Up to 30% reduction in time-to-market
Sustainability in medical materials
Although sterility remains a priority, there is growing adoption of:
- Recyclable polymers
- Bio-based materials
- Circular economy systems and actions for sustainability in businesses
Sustainability already influences more than 35% of purchasing decisions, driving innovation without compromising safety or performance.
Opportunities for medical injection molding manufacturers
The current landscape offers significant opportunities for companies with capabilities in:
- Technical plastic injection molding
- LSR silicone processing
- Cleanroom manufacturing
- Custom component development / contract manufacturing
The combination of strict regulation, technological innovation, and increasing demand requires highly specialized industrial partners.
OSF Plastic as a strategic partner for medical innovation
Injection molding in the medical sector will continue to be a critical technology in the evolution of healthcare, driven by digitalization and sustainability, among other factors.
In this context, OSF Plastic positions itself as a strategic partner for the development and manufacturing of high-precision medical components in plastic and silicone, tailored to the most demanding market standards.